Bharat Biotech starts trials for booster dose of Covaxin at AIIMS, Delhi and Patna

The booster dose will be given to the participants after six months when they had received their second dose during the trial.

Covaxin manufacturer, Bharat Biotech today started trials for the booster dose of the vaccine at AIIMS, Delhi and Patna. It will be conducted in phase two clinical trial participants.

The booster dose will be given to the participants after six months when they had received their second dose during the trial.

advt

Last month, the Drug Controller General of India had given permission to Bharat Biotech to conduct clinical trials for a third booster dose of Covaxin.

Tags
advt

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button